Advanced search

Authors whose works are in public domain in at least one jurisdiction

List of works by A Musolino

1-41 of 41 results

View this query on the Wikidata Query Service
Immunoglobulin G fragment C receptor polymorphisms and clinical efficacy of trastuzumab-based therapy in patients with HER-2/neu-positive metastatic breast cancer.

scientific article
Preoperative chemotherapy plus trastuzumab, lapatinib, or both in human epidermal growth factor receptor 2-positive operable breast cancer: results of the randomized phase II CHER-LOB study

scientific article
Multifactorial central nervous system recurrence susceptibility in patients with HER2-positive breast cancer: epidemiological and clinical data from a population-based cancer registry study.

scientific article
BRCA mutations, molecular markers, and clinical variables in early-onset breast cancer: a population-based study.

scientific article
Prospective Biomarker Analysis of the Randomized CHER-LOB Study Evaluating the Dual Anti-HER2 Treatment With Trastuzumab and Lapatinib Plus Chemotherapy as Neoadjuvant Therapy for HER2-Positive Breast Cancer

scientific article
Nine weeks versus 1 year adjuvant trastuzumab in combination with chemotherapy: final results of the phase III randomized Short-HER study‡

scientific article published on 01 December 2018
Phase II, randomized, placebo-controlled study of dovitinib in combination with fulvestrant in postmenopausal patients with HR+, HER2- breast cancer that had progressed during or after prior endocrine therapy

scientific article published on 10 February 2017
Evaluation of HER-2/neu amplification and other biological markers as predictors of response to neoadjuvant anthracycline-based chemotherapy in primary breast cancer: the role of anthracycline dose intensity

scientific article published on 01 April 2006
Activity and safety of dose-adjusted infusional cyclophosphamide, doxorubicin, vincristine, and prednisone chemotherapy with rituximab in very elderly patients with poor-prognostic untreated diffuse large B-cell non-Hodgkin lymphoma.

scientific article
Role of immunoglobulin G fragment C receptor polymorphism-mediated antibody-dependant cellular cytotoxicity in colorectal cancer treated with cetuximab therapy.

scientific article
A randomized phase II trial of ridaforolimus, dalotuzumab, and exemestane compared with ridaforolimus and exemestane in patients with advanced breast cancer

scientific article
Association of tumor-infiltrating lymphocytes with distant disease-free survival in the ShortHER randomized adjuvant trial for patients with early HER2+ breast cancer

scientific article published on 01 March 2019
Immunoglobulin G fragment C receptor polymorphisms and efficacy of preoperative chemotherapy plus trastuzumab and lapatinib in HER2-positive breast cancer.

scientific article published on 5 July 2016
The Breast Avastin Trial: phase II study of bevacizumab maintenance therapy after induction chemotherapy with docetaxel and capecitabine for the first-line treatment of patients with locally recurrent or metastatic breast cancer

scientific article published on 3 February 2013
A breast cancer patient from Italy with germline mutations in both the BRCA1 and BRCA2 genes

scientific article published on 01 May 2005
Brain Metastasis Prediction by Transcriptomic Profiling in Triple-Negative Breast Cancer.

scientific article published on 8 September 2016
Human epidermal growth factor receptor 2 status and interval breast cancer in a population-based cancer registry study

scientific article published on 14 May 2012
Prognostic risk factors for treatment decision in pT1a,b N0M0 HER2-positive breast cancers

scientific article published on 7 December 2015
Hypertriglyceridaemia with bexarotene in cutaneous T cell lymphoma: the role of omega-3 fatty acids.

scientific article published on 4 February 2009
Efficacy and safety of Everolimus and Exemestane in hormone-receptor positive (HR+) human-epidermal-growth-factor negative (HER2-) advanced breast cancer patients: New insights beyond clinical trials. The EVA study

scientific article published on 13 July 2017
Homologous Recombination Repair Deficiency and the Immune Response in Breast Cancer: A Literature Review

scientific article published on 02 January 2020
p73 and p53 pathway in human breast cancers

scientific article published on 01 April 2007
Intracranial hematopoiesis in a patient with AIDS-related central nervous system lymphoma and severe pancytopenia

scientific article published on 01 May 2007
Everolimus (EVE) and exemestane (EXE) in patients with advanced breast cancer aged ≥ 65 years: new lessons for clinical practice from the EVA study

scientific article published on 07 August 2018
Lung cancer in patients with chronic lymphocytic leukemia: does the HER-2 oncogene play a role?

scientific article published on 26 August 2005
Prognostic impact of interval breast cancer detection in women with pT1a N0M0 breast cancer with HER2-positive status: Results from a multicentre population-based cancer registry study

scientific article published on 23 November 2017
Nab-paclitaxel after docetaxel hypersensitivity reaction: case report and literature review

scientific article published on 23 October 2017
A multivariable prognostic score to guide systemic therapy in early-stage HER2-positive breast cancer: a retrospective study with an external evaluation

scientific article published on 01 November 2020
Mechanism of Action and Clinical Efficacy of CDK4/6 Inhibitors in BRCA-Mutated, Estrogen Receptor-Positive Breast Cancers: Case Report and Literature Review

scientific article published on 13 August 2019
Anti-PD-1-related cryoglobulinemia during treatment with nivolumab in NSCLC patient.

scientific article
Metronomic chemotherapy for advanced breast cancer patients in the real world practice: Final results of the VICTOR-6 study

scientific article published on 22 August 2019
Prognostic Role of Immunoglobulin G Fragment C Receptor Polymorphisms in Solid Tumors.

scientific article published on 28 September 2017
PIK3CA mutation in the ShortHER randomized adjuvant trial for patients with early HER2+ breast cancer: association with prognosis and integration with PAM50 subtype

scientific article published on 25 August 2020
BOLERO-3 results: pharmacological activity or pharmacokinetic effect?

scientific article published on 01 July 2014
Preclinical In Vivo Validation of the RAD51 Test for Identification of Homologous Recombination-Deficient Tumors and Patient Stratification

Validation of the AJCC prognostic stage for HER2-positive breast cancer in the ShortHER trial

scientific article published on 21 November 2019
Salivary MicroRNA for Diagnosis of Cancer and Systemic Diseases: A Systematic Review

scientific article published on 30 January 2020
FCGR, Cetuximab, and Colorectal Cancer Survival-Letter.

scientific article published in October 2016
Lomustine (chloroethylnitrosourea [CCNU]), ifosfamide, bleomycin, vincristine, and cisplatin (CIBO-P) is an effective regimen for patients with poor prognostic refractory or multiple disease recurrent aggressive non-Hodgkin lymphoma

scientific article
My best choice after a round trip from illness

scientific article published on 23 August 2017
Correction: Everolimus (EVE) and exemestane (EXE) in patients with advanced breast cancer aged ≥ 65 years: new lessons for clinical practice from the EVA study

scientific article published on 02 October 2018

Paulina is supported by:

About Paulina

Help